Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate

PURPOSE: After peptide receptor radionuclide therapy (PRRT), renal toxicity may occur, particular in PRRT with (90)Y-labelled somatostatin analogues. Risk factors have been identified for increased probability of developing renal toxicity after PRRT, including hypertension, diabetes and age. We inve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Nucl Med Mol Imaging
Autors principals: Bergsma, Hendrik, Konijnenberg, Mark W., van der Zwan, Wouter A., Kam, Boen L. R., Teunissen, Jaap J. M., Kooij, Peter P., Mauff, Katya A. L., Krenning, Eric P., Kwekkeboom, Dik J.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4969358/
https://ncbi.nlm.nih.gov/pubmed/27160225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3382-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars